Ioflupane I-123

DB08824ApprovedInvestigationalSmall moleculeRadioactive Diagnostic Agent

Ioflupane I-123 is a radiopharmaceutical used in single photon emission computed tomography (SPECT) brain imaging to help diagnose patients with suspected Parkinsonian syndromes. A product used in medical brain imaging to help healthcare providers diagnose Parkinson's Disease.

Chemical structure of Ioflupane I-123
Mechanism
Curator reviewed
Primary indication
Ioflupane I-123 is a SPECT (single photon emission computerized tomography) agent used to distinguish between Parkinson’s syndrome tremors and essential tremor.Curator reviewed · 1 structured indication
Formula / weight
C18H23FINO2 · 427.291 g/mol (avg)
First approval
United States, 2011 · European Union, 2016
Also known as
123I-FP-CIT · 123I-Ioflupane · Iodine ioflupane (123I) · Ioflupane (123I) · Ioflupane I 123
Brand names
  • Datscan
  • Striascan

Resolves to

Structure
InChIKeyHXWLAJVUJSVENX-HFIFKADTSA-NSMILES[H][C@]12CC[C@]([H])([C@H]([C@H](C1)C1=CC=C([123I])C=C1)C(=O)OC)N2CCCF
Transporters

What you can answer from here — as of March 03, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
773Drug interactionsStructured to mechanism, not free text
Sign in
15Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
19Marketed productsAcross 6 countries and 7 labellers
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ioflupane I-123, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account